Position in EDIT
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$48,975
+$26,165 QoQ
Shares Held
19,828
+78.2% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Derivatives in EDIT
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$15,195
PutShares
1,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names. EDIT ranks #85 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,200 | $58,503,546 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
58,925 | $45,527,812 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,859 | $35,025,567 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,684 | $29,330,533 | |
| 5 | RPRX |
Royalty Pharma plc
|
292,921 | $14,051,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
56,633 | $9,572,109 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
146,462 | $9,183,167 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
13,914 | $7,283,561 |
All Filings in EDIT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,975 | 19,828 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $22,810 | 11,127 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $64,205 | 18,503 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $45,599 | 20,727 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $12,766 | 11,006 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,104 | 11,106 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $45,506 | 13,345 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $75,784 | 16,228 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $114,401 | 15,418 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $171,146 | 16,895 | Shares | Sole | 2024-02-12 | |
| 2023-12-31 | $15,195 | 1,500 | Put | Sole | 2024-02-12 | |
| 2023-09-30 | $162,216 | 20,797 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $164 | 20 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $180,533 | 21,936 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $127,194 | 17,544 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $156,502 | 17,644 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $175,533 | 14,341 | Shares | Sole | 2022-11-09 | |
| 2021-12-31 | $286,262 | 10,782 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,439,114 | 35,032 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,305,623 | 58,362 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,428,714 | 34,017 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,736,835 | 24,773 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $710,900 | 25,335 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $519,572 | 17,565 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $218,824 | 11,035 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||